{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T08:16:13Z","timestamp":1773389773603,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Chronic obstructive pulmonary disease (COPD) is characterized by airflow obstruction and persistent inflammation in the airways and lung parenchyma. Oxidative stress contributes to the pathogenesis of COPD. Interleukin<jats:bold>(<\/jats:bold>IL)-32 expression has been reported to increase in the lung tissue of patients with COPD. Here, we show that IFN\u03b3 upregulated IL-32 expression and that oxidative stress augmented IFN\u03b3-induced-IL-32 expression in airway epithelial cells. We further investigated transcriptional regulation responsible for IFN\u03b3 induced IL-32 expression in human airway epithelial cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Human bronchial epithelial (HBE) cells were stimulated with H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>and IFN\u03b3, and IL-32 expression was evaluated. The cell viability was confirmed by MTT assay. The intracellular signaling pathways regulating IL-32 expression were investigated by examining the regulatory effects of MAPK inhibitors and JAK inhibitor after treatment with H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>and IFN\u03b3, and by using a ChIP assay to identify transcription factors (i.e. c-Jun, CREB) binding to the IL-32 promoter. Promoter activity assays were conducted after mutations were introduced into binding sites of c-Jun and CREB in the IL-32 promoter. IL-32 expression was also examined in HBE cells in which the expression of either c-Jun or CREB was knocked out by siRNA of indicated transcription factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were no significant differences of cell viability among groups. After stimulation with H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>or IFN\u03b3 for 48 hours, IL-32 expression in HBE cells was increased by IFN\u03b3 and synergistically upregulated by the addition of H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>. The H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>augmented IFN\u03b3 induced IL-32 mRNA expression was suppressed by a JNK inhibitor, but not by MEK inhibitor, p38 inhibitor, and JAK inhibitor I. Significant binding of c-Jun and CREB to the IL-32 promoter was observed in the IFN\u03b3 + H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>stimulated HBE cells. Introducing mutations into the c-Jun\/CREB binding sites in the IL-32 promoter prominently suppressed its transcriptional activity. Further, knocking down CREB expression by siRNA resulted in significant suppression of IL-32 induction by IFN\u03b3 and H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>in HBE cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>IL-32 expression in airway epithelium may be augmented by inflammation and oxidative stress, which may occur in COPD acute exacerbation. c-Jun and CREB are key transcriptional factors in IFN\u03b3 and H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>induced IL-32 expression.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1465-9921-13-19","type":"journal-article","created":{"date-parts":[[2012,3,14]],"date-time":"2012-03-14T07:14:19Z","timestamp":1331709259000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Oxidative stress induced Interleukin-32 mRNA expression in human bronchial epithelial cells"],"prefix":"10.1186","volume":"13","author":[{"given":"Megumi","family":"Kudo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiko","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Kinose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akane","family":"Haruna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Marumo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuma","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyohiro","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Muro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Date","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiaki","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,14]]},"reference":[{"issue":"6","key":"1217_CR1","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1165\/rcmb.2009-0220TR","volume":"41","author":"PJ Barnes","year":"2009","unstructured":"Barnes PJ: The cytokine network in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2009, 41 (6): 631-638. 10.1165\/rcmb.2009-0220TR.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"23","key":"1217_CR2","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1056\/NEJMra0804752","volume":"360","author":"MG Cosio","year":"2009","unstructured":"Cosio MG, Saetta M, Agusti A: Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med. 2009, 360 (23): 2445-2454. 10.1056\/NEJMra0804752.","journal-title":"N Engl J Med"},{"issue":"2","key":"1217_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1183\/09031936.06.00025805","volume":"27","author":"AD Lopez","year":"2006","unstructured":"Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, Schmid V, Buist S: Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006, 27 (2): 397-412. 10.1183\/09031936.06.00025805.","journal-title":"Eur Respir J"},{"issue":"2","key":"1217_CR4","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.4049\/jimmunol.0900904","volume":"183","author":"H Kouzaki","year":"2009","unstructured":"Kouzaki H, O'Grady SM, Lawrence CB, Kita H: Proteases induce production of thymic stromal lymphopoietin by airway epithelial cells through protease-activated receptor-2. J Immunol. 2009, 183 (2): 1427-1434. 10.4049\/jimmunol.0900904.","journal-title":"J Immunol"},{"issue":"5","key":"1217_CR5","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1165\/rcmb.2006-0199TR","volume":"35","author":"D Proud","year":"2006","unstructured":"Proud D, Chow CW: Role of viral infections in asthma and chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2006, 35 (5): 513-518. 10.1165\/rcmb.2006-0199TR.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"1217_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1165\/ajrcmb.27.1.4789","volume":"27","author":"A Richter","year":"2002","unstructured":"Richter A, O'Donnell RA, Powell RM, Sanders MW, Holgate ST, Djukanovic R, Davies DE: Autocrine ligands for the epidermal growth factor receptor mediate interleukin-8 release from bronchial epithelial cells in response to cigarette smoke. Am J Respir Cell Mol Biol. 2002, 27 (1): 85-90.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"1217_CR7","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1164\/ajrccm.163.6.9908135","volume":"163","author":"H Takizawa","year":"2001","unstructured":"Takizawa H, Tanaka M, Takami K, Ohtoshi T, Ito K, Satoh M, Okada Y, Yamasawa F, Nakahara K, Umeda A: Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med. 2001, 163 (6): 1476-1483.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"1217_CR8","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.4049\/jimmunol.181.4.2790","volume":"181","author":"S Ying","year":"2008","unstructured":"Ying S, O'Connor B, Ratoff J, Meng Q, Fang C, Cousins D, Zhang G, Gu S, Gao Z, Shamji B, et al: Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. J Immunol. 2008, 181 (4): 2790-2798.","journal-title":"J Immunol"},{"issue":"1","key":"1217_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0891-5849(89)90094-4","volume":"7","author":"T Nakayama","year":"1989","unstructured":"Nakayama T, Church DF, Pryor WA: Quantitative analysis of the hydrogen peroxide formed in aqueous cigarette tar extracts. Free Radic Biol Med. 1989, 7 (1): 9-15. 10.1016\/0891-5849(89)90094-4.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1217_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1385\/CBB:43:1:167","volume":"43","author":"I Rahman","year":"2005","unstructured":"Rahman I: Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms. Cell Biochem Biophys. 2005, 43 (1): 167-188. 10.1385\/CBB:43:1:167.","journal-title":"Cell Biochem Biophys"},{"issue":"2","key":"1217_CR11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4049\/jimmunol.148.2.597","volume":"148","author":"CA Dahl","year":"1992","unstructured":"Dahl CA, Schall RP, He HL, Cairns JS: Identification of a novel gene expressed in activated natural killer cells and T cells. J Immunol. 1992, 148 (2): 597-603.","journal-title":"J Immunol"},{"issue":"9","key":"1217_CR12","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1073\/pnas.0511233103","volume":"103","author":"LA Joosten","year":"2006","unstructured":"Joosten LA, Netea MG, Kim SH, Yoon DY, Oppers-Walgreen B, Radstake TR, Barrera P, van de Loo FA, Dinarello CA, van den Berg WB: IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci USA. 2006, 103 (9): 3298-3303. 10.1073\/pnas.0511233103.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"1217_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.cyto.2009.03.007","volume":"46","author":"H Kobayashi","year":"2009","unstructured":"Kobayashi H, Lin PC: Molecular characterization of IL-32 in human endothelial cells. Cytokine. 2009, 46 (3): 351-358. 10.1016\/j.cyto.2009.03.007.","journal-title":"Cytokine"},{"issue":"3","key":"1217_CR14","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1365-2249.2007.03439.x","volume":"149","author":"M Shioya","year":"2007","unstructured":"Shioya M, Nishida A, Yagi Y, Ogawa A, Tsujikawa T, Kim-Mitsuyama S, Takayanagi A, Shimizu N, Fujiyama Y, Andoh A: Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol. 2007, 149 (3): 480-486. 10.1111\/j.1365-2249.2007.03439.x.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"1217_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/intimm\/dxh339","volume":"18","author":"C Goda","year":"2006","unstructured":"Goda C, Kanaji T, Kanaji S, Tanaka G, Arima K, Ohno S, Izuhara K: Involvement of IL32 in activation-induced cell death in T cells. Int Immunol. 2006, 18 (2): 233-240.","journal-title":"Int Immunol"},{"issue":"9","key":"1217_CR16","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1073\/pnas.0712381105","volume":"105","author":"MG Netea","year":"2008","unstructured":"Netea MG, Lewis EC, Azam T, Joosten LA, Jaekal J, Bae SY, Dinarello CA, Kim SH: Interleukin-32 induces the differentiation of monocytes into macrophage-like cells. Proc Natl Acad Sci USA. 2008, 105 (9): 3515-3520. 10.1073\/pnas.0712381105.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"1217_CR17","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1073\/pnas.0511206103","volume":"103","author":"D Novick","year":"2006","unstructured":"Novick D, Rubinstein M, Azam T, Rabinkov A, Dinarello CA, Kim SH: Proteinase 3 is an IL-32 binding protein. Proc Natl Acad Sci USA. 2006, 103 (9): 3316-3321. 10.1073\/pnas.0511206103.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1217_CR18","doi-asserted-by":"publisher","first-page":"R166","DOI":"10.1186\/ar2074","volume":"8","author":"H Shoda","year":"2006","unstructured":"Shoda H, Fujio K, Yamaguchi Y, Okamoto A, Sawada T, Kochi Y, Yamamoto K: Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases. Arthritis Res Ther. 2006, 8 (6): R166-10.1186\/ar2074.","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"1217_CR19","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1164\/rccm.200804-646OC","volume":"178","author":"F Calabrese","year":"2008","unstructured":"Calabrese F, Baraldo S, Bazzan E, Lunardi F, Rea F, Maestrelli P, Turato G, Lokar-Oliani K, Papi A, Zuin R, et al: IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008, 178 (9): 894-901. 10.1164\/rccm.200804-646OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"1217_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1164\/rccm.2111032","volume":"166","author":"Y Higashimoto","year":"2002","unstructured":"Higashimoto Y, Elliott WM, Behzad AR, Sedgwick EG, Takei T, Hogg JC, Hayashi S: Inflammatory mediator mRNA expression by adenovirus E1A-transfected bronchial epithelial cells. Am J Respir Crit Care Med. 2002, 166 (2): 200-207. 10.1164\/rccm.2111032.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1217_CR21","first-page":"131","volume":"22","author":"SH Kim","year":"2005","unstructured":"Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA: Interleukin-32: a cytokine and inducer of TNFalpha. Immunity. 2005, 22 (1): 131-142.","journal-title":"Immunity"},{"issue":"2","key":"1217_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.bbrc.2008.07.027","volume":"374","author":"MO Cevik","year":"2008","unstructured":"Cevik MO, Katsuyama M, Kanda S, Kaneko T, Iwata K, Ibi M, Matsuno K, Kakehi T, Cui W, Sasaki M, et al: The AP-1 site is essential for the promoter activity of NOX1\/NADPH oxidase, a vascular superoxide-producing enzyme: Possible involvement of the ERK1\/2-JunB pathway. Biochem Biophys Res Commun. 2008, 374 (2): 351-355. 10.1016\/j.bbrc.2008.07.027.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1 Suppl","key":"1217_CR23","doi-asserted-by":"publisher","first-page":"e532","DOI":"10.1111\/j.1365-2567.2008.03025.x","volume":"128","author":"JW Kang","year":"2009","unstructured":"Kang JW, Choi SC, Cho MC, Kim HJ, Kim JH, Lim JS, Kim SH, Han JY, Yoon DY: A proinflammatory cytokine interleukin-32beta promotes the production of an anti-inflammatory cytokine interleukin-10. Immunology. 2009, 128 (1 Suppl): e532-540.","journal-title":"Immunology"},{"issue":"4","key":"1217_CR24","doi-asserted-by":"publisher","first-page":"e1985","DOI":"10.1371\/journal.pone.0001985","volume":"3","author":"W Li","year":"2008","unstructured":"Li W, Liu Y, Mukhtar MM, Gong R, Pan Y, Rasool ST, Gao Y, Kang L, Hao Q, Peng G, et al: Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection. PLoS One. 2008, 3 (4): e1985-10.1371\/journal.pone.0001985.","journal-title":"PLoS One"},{"issue":"8","key":"1217_CR25","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1371\/journal.pmed.0030277","volume":"3","author":"MG Netea","year":"2006","unstructured":"Netea MG, Azam T, Lewis EC, Joosten LA, Wang M, Langenberg D, Meng X, Chan ED, Yoon DY, Ottenhoff T, et al: Mycobacterium tuberculosis induces interleukin-32 production through a caspase-1\/IL-18\/interferon-gamma-dependent mechanism. PLoS Med. 2006, 3 (8): e277-10.1371\/journal.pmed.0030277.","journal-title":"PLoS Med"},{"issue":"2","key":"1217_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.imlet.2008.01.007","volume":"117","author":"ST Rasool","year":"2008","unstructured":"Rasool ST, Tang H, Wu J, Li W, Mukhtar MM, Zhang J, Mu Y, Xing HX, Wu J, Zhu Y: Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication. Immunol Lett. 2008, 117 (2): 161-167. 10.1016\/j.imlet.2008.01.007.","journal-title":"Immunol Lett"},{"issue":"9","key":"1217_CR27","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.4049\/jimmunol.0902667","volume":"185","author":"W Li","year":"2010","unstructured":"Li W, Sun W, Liu L, Yang F, Li Y, Chen Y, Fang J, Zhang W, Wu J, Zhu Y: IL-32: a host proinflammatory factor against influenza viral replication is upregulated by aberrant epigenetic modifications during influenza A virus infection. J Immunol. 2010, 185 (9): 5056-5065. 10.4049\/jimmunol.0902667.","journal-title":"J Immunol"},{"key":"1217_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2466-9-25","volume":"9","author":"N Louhelainen","year":"2009","unstructured":"Louhelainen N, Rytila P, Haahtela T, Kinnula VL, Djukanovic R: Persistence of oxidant and protease burden in the airways after smoking cessation. BMC Pulm Med. 2009, 9: 25-10.1186\/1471-2466-9-25.","journal-title":"BMC Pulm Med"},{"issue":"7","key":"1217_CR29","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1513\/pats.200701-003FM","volume":"4","author":"A Anzueto","year":"2007","unstructured":"Anzueto A, Sethi S, Martinez FJ: Exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2007, 4 (7): 554-564. 10.1513\/pats.200701-003FM.","journal-title":"Proc Am Thorac Soc"},{"issue":"2","key":"1217_CR30","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.cyto.2011.07.010","volume":"56","author":"C Moermans","year":"2011","unstructured":"Moermans C, Heinen V, Nguyen M, Henket M, Sele J, Manise M, Corhay JL, Louis R: Local and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary disease. Cytokine. 2011, 56 (2): 298-304. 10.1016\/j.cyto.2011.07.010.","journal-title":"Cytokine"},{"issue":"3","key":"1217_CR31","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1164\/ajrccm.164.3.2010017","volume":"164","author":"RE Kanner","year":"2001","unstructured":"Kanner RE, Anthonisen NR, Connett JE: Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med. 2001, 164 (3): 358-364.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"1217_CR32","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/art.24299","volume":"60","author":"SH Mun","year":"2009","unstructured":"Mun SH, Kim JW, Nah SS, Ko NY, Lee JH, Kim JD, Kim do K, Kim HS, Choi JD, Kim SH: Tumor necrosis factor alpha-induced interleukin-32 is positively regulated via the Syk\/protein kinase Cdelta\/JNK pathway in rheumatoid synovial fibroblasts. Arthritis Rheum. 2009, 60 (3): 678-685. 10.1002\/art.24299. 3","journal-title":"Arthritis Rheum"},{"issue":"26","key":"1217_CR33","doi-asserted-by":"publisher","first-page":"17868","DOI":"10.1074\/jbc.M900368200","volume":"284","author":"A Nishida","year":"2009","unstructured":"Nishida A, Andoh A, Inatomi O, Fujiyama Y: Interleukin-32 expression in the pancreas. J Biol Chem. 2009, 284 (26): 17868-17876. 10.1074\/jbc.M900368200.","journal-title":"J Biol Chem"},{"issue":"1","key":"1217_CR34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/nar\/26.1.362","volume":"26","author":"T Heinemeyer","year":"1998","unstructured":"Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV, Ignatieva EV, Ananko EA, Podkolodnaya OA, Kolpakov FA, et al: Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res. 1998, 26 (1): 362-367. 10.1093\/nar\/26.1.362.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"1217_CR35","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.4049\/jimmunol.179.9.6237","volume":"179","author":"SJ Tudhope","year":"2007","unstructured":"Tudhope SJ, Catley MC, Fenwick PS, Russell RE, Rumsey WL, Newton R, Barnes PJ, Donnelly LE: The role of IkappaB kinase 2, but not activation of NF-kappaB, in the release of CXCR3 ligands from IFN-gamma-stimulated human bronchial epithelial cells. J Immunol. 2007, 179 (9): 6237-6245.","journal-title":"J Immunol"},{"issue":"10","key":"1217_CR36","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/j.cellsig.2006.02.001","volume":"18","author":"IK Aggeli","year":"2006","unstructured":"Aggeli IK, Gaitanaki C, Beis I: Involvement of JNKs and p38-MAPK\/MSK1 pathways in H2O2-induced upregulation of heme oxygenase-1 mRNA in H9c2 cells. Cell Signal. 2006, 18 (10): 1801-1812. 10.1016\/j.cellsig.2006.02.001.","journal-title":"Cell Signal"},{"issue":"39","key":"1217_CR37","doi-asserted-by":"publisher","first-page":"28395","DOI":"10.1074\/jbc.M705142200","volume":"282","author":"CH Teng","year":"2007","unstructured":"Teng CH, Huang WN, Meng TC: Several dual specificity phosphatases coordinate to control the magnitude and duration of JNK activation in signaling response to oxidative stress. J Biol Chem. 2007, 282 (39): 28395-28407. 10.1074\/jbc.M705142200.","journal-title":"J Biol Chem"},{"issue":"5","key":"1217_CR38","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.cdd.4402088","volume":"14","author":"S Zhang","year":"2007","unstructured":"Zhang S, Lin Y, Kim YS, Hande MP, Liu ZG, Shen HM: c-Jun N-terminal kinase mediates hydrogen peroxide-induced cell death via sustained poly (ADP-ribose) polymerase-1 activation. Cell Death Differ. 2007, 14 (5): 1001-1010.","journal-title":"Cell Death Differ"},{"issue":"2","key":"1217_CR39","doi-asserted-by":"publisher","first-page":"L370","DOI":"10.1152\/ajplung.90205.2008","volume":"295","author":"S Kumar","year":"2008","unstructured":"Kumar S, Sun X, Wedgwood S, Black SM: Hydrogen peroxide decreases endothelial nitric oxide synthase promoter activity through the inhibition of AP-1 activity. Am J Physiol Lung Cell Mol Physiol. 2008, 295 (2): L370-377. 10.1152\/ajplung.90205.2008.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"6","key":"1217_CR40","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1189\/jlb.1007676","volume":"83","author":"HA Kim","year":"2008","unstructured":"Kim HA, Jeon SH, Seo GY, Park JB, Kim PH: TGF-beta1 and IFN-gamma stimulate mouse macrophages to express BAFF via different signaling pathways. J Leukoc Biol. 2008, 83 (6): 1431-1439. 10.1189\/jlb.1007676.","journal-title":"J Leukoc Biol"},{"issue":"6","key":"1217_CR41","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1089\/107999004323142196","volume":"24","author":"L Liu","year":"2004","unstructured":"Liu L, Wang Y, Fan Y, Li CL, Chang ZL: IFN-gamma activates cAMP\/PKA\/CREB signaling pathway in murine peritoneal macrophages. J Interferon Cytokine Res. 2004, 24 (6): 334-342. 10.1089\/107999004323142196.","journal-title":"J Interferon Cytokine Res"},{"issue":"2","key":"1217_CR42","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1189\/jlb.1206763","volume":"82","author":"X Hu","year":"2007","unstructured":"Hu X, Chen J, Wang L, Ivashkiv LB: Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation. J Leukoc Biol. 2007, 82 (2): 237-243. 10.1189\/jlb.1206763.","journal-title":"J Leukoc Biol"},{"issue":"5","key":"1217_CR43","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.immuni.2006.02.014","volume":"24","author":"X Hu","year":"2006","unstructured":"Hu X, Paik PK, Chen J, Yarilina A, Kockeritz L, Lu TT, Woodgett JR, Ivashkiv LB: IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB\/AP-1 proteins. Immunity. 2006, 24 (5): 563-574. 10.1016\/j.immuni.2006.02.014.","journal-title":"Immunity"},{"issue":"6","key":"1217_CR44","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1136\/ard.2006.060269","volume":"66","author":"R Ahmad","year":"2007","unstructured":"Ahmad R, Qureshi HY, El Mabrouk M, Sylvester J, Ahmad M, Zafarullah M: Inhibition of interleukin 1-induced matrix metalloproteinase 13 expression in human chondrocytes by interferon gamma. Ann Rheum Dis. 2007, 66 (6): 782-789. 10.1136\/ard.2006.060269.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1217_CR45","doi-asserted-by":"publisher","first-page":"6981","DOI":"10.4049\/jimmunol.0901045","volume":"183","author":"D Strassheim","year":"2009","unstructured":"Strassheim D, Riddle SR, Burke DL, Geraci MW, Stenmark KR: Prostacyclin inhibits IFN-gamma-stimulated cytokine expression by reduced recruitment of CBP\/p300 to STAT1 in a SOCS-1-independent manner. J Immunol. 2009, 183 (11): 6981-6988. 10.4049\/jimmunol.0901045.","journal-title":"J Immunol"},{"issue":"26","key":"1217_CR46","doi-asserted-by":"publisher","first-page":"15092","DOI":"10.1073\/pnas.93.26.15092","volume":"93","author":"JJ Zhang","year":"1996","unstructured":"Zhang JJ, Vinkemeier U, Gu W, Chakravarti D, Horvath CM, Darnell JE: Two contact regions between Stat1 and CBP\/p300 in interferon gamma signaling. Proc Natl Acad Sci USA. 1996, 93 (26): 15092-15096. 10.1073\/pnas.93.26.15092.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"1217_CR47","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/jcb.21535","volume":"102","author":"Z Du","year":"2007","unstructured":"Du Z, Wei L, Murti A, Pfeffer SR, Fan M, Yang CH, Pfeffer LM: Non-conventional signal transduction by type 1 interferons: the NF-kappaB pathway. J Cell Biochem. 2007, 102 (5): 1087-1094. 10.1002\/jcb.21535.","journal-title":"J Cell Biochem"},{"issue":"12","key":"1217_CR48","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1089\/jir.2005.25.799","volume":"25","author":"K Pokrovskaja","year":"2005","unstructured":"Pokrovskaja K, Panaretakis T, Grander D: Alternative signaling pathways regulating type I interferon-induced apoptosis. J Interferon Cytokine Res. 2005, 25 (12): 799-810. 10.1089\/jir.2005.25.799.","journal-title":"J Interferon Cytokine Res"},{"issue":"6","key":"1217_CR49","first-page":"407","volume":"4","author":"H Li","year":"2007","unstructured":"Li H, Gade P, Xiao W, Kalvakolanu DV: The interferon signaling network and transcription factor C\/EBP-beta. Cell Mol Immunol. 2007, 4 (6): 407-418.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"1217_CR50","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1365-2567.2008.02929.x","volume":"127","author":"J Blanchette","year":"2009","unstructured":"Blanchette J, Abu-Dayyeh I, Hassani K, Whitcombe L, Olivier M: Regulation of macrophage nitric oxide production by the protein tyrosine phosphatase Src homology 2 domain phosphotyrosine phosphatase 1 (SHP-1). Immunology. 2009, 127 (1): 123-133. 10.1111\/j.1365-2567.2008.02929.x.","journal-title":"Immunology"},{"issue":"4-5","key":"1217_CR51","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/0748233709102209","volume":"25","author":"H Zhang","year":"2009","unstructured":"Zhang H, Forman HJ: Signaling pathways involved in phase II gene induction by alpha, beta-unsaturated aldehydes. Toxicol Ind Health. 2009, 25 (4-5): 269-278. 10.1177\/0748233709102209.","journal-title":"Toxicol Ind Health"},{"issue":"3","key":"1217_CR52","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0092-8674(00)81118-6","volume":"85","author":"Y Kamei","year":"1996","unstructured":"Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, et al: A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell. 1996, 85 (3): 403-414. 10.1016\/S0092-8674(00)81118-6.","journal-title":"Cell"},{"issue":"3","key":"1217_CR53","first-page":"295","volume":"5","author":"DM Benbrook","year":"1990","unstructured":"Benbrook DM, Jones NC: Heterodimer formation between CREB and JUN proteins. Oncogene. 1990, 5 (3): 295-302.","journal-title":"Oncogene"},{"issue":"7","key":"1217_CR54","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.4049\/jimmunol.0901913","volume":"184","author":"X Bai","year":"2010","unstructured":"Bai X, Kim SH, Azam T, McGibney MT, Huang H, Dinarello CA, Chan ED: IL-32 is a host protective cytokine against Mycobacterium tuberculosis in differentiated THP-1 human macrophages. J Immunol. 2010, 184 (7): 3830-3840. 10.4049\/jimmunol.0901913.","journal-title":"J Immunol"},{"issue":"45","key":"1217_CR55","doi-asserted-by":"publisher","first-page":"16309","DOI":"10.1073\/pnas.0508237102","volume":"102","author":"MG Netea","year":"2005","unstructured":"Netea MG, Azam T, Ferwerda G, Girardin SE, Walsh M, Park JS, Abraham E, Kim JM, Yoon DY, Dinarello CA, et al: IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1dependent mechanism. Proc Natl Acad Sci USA. 2005, 102 (45): 16309-16314. 10.1073\/pnas.0508237102.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1217_CR56","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1365-2567.2008.02917.x","volume":"126","author":"JD Choi","year":"2009","unstructured":"Choi JD, Bae SY, Hong JW, Azam T, Dinarello CA, Her E, Choi WS, Kim BK, Lee CK, Yoon DY, et al: Identification of the most active interleukin-32 isoform. Immunology. 2009, 126 (4): 535-542. 10.1111\/j.1365-2567.2008.02917.x.","journal-title":"Immunology"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-13-19.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T02:55:27Z","timestamp":1687316127000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/1465-9921-13-19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,14]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1217"],"URL":"https:\/\/doi.org\/10.1186\/1465-9921-13-19","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,14]]},"assertion":[{"value":"20 December 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"19"}}